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C H R I S T O P H E R  D .  B U C K L E Y
Immune cells called macrophages com-monly function as scavenger-like (phago-cytic) cells that ingest and remove damaged 
cells. Writing in Nature, Culemann et al.1 
report that the macrophages present in joints 
also fulfil an unexpectedly different role. 
Macrophages derive from two main cellular 
lineages2. One lineage arises from bone-mar-
row-derived immune cells called monocytes. 
The other lineage is monocyte independent, 
and is derived from cells that disperse into the 
tissues during embryonic development2. The 
tissue-resident macrophages in this lineage 
have distinctive gene-expression profiles3,4 
that depend on the particular tissue in which 
they reside. 
Rheumatoid arthritis is an autoimmune 
disease associated with inflammation and the 
destruction of the cartilage and bone in joints, 
and macrophages have a key role in the initia-
tion of this condition. However, little is known 
about the relative contribution of the two line-
ages of macrophages to the development and 
function of joints in health and disease. To add 
to the complexity, macrophages exist as various 
subsets, some of which are pro-inflammatory 
whereas others limit inflammation and aid tis-
sue repair5.
To study macrophages, the authors began by 
focusing on a protein called CX3CR1, which 
is expressed on monocytes and macrophages. 
The authors engineered CX3CR1-expressing 
cells in mice to make a red fluorescent protein 
so that the cells could be tracked in vivo. These 
cells were monitored in knee joints using an 
approach called 3D light-sheet fluorescence 
microscopy, and the joint tissue was treated 
using a technique that enabled the authors to 
obtain ‘optical clearance’, which improves the 
visualization of internal structures6.
The authors’ observations unexpectedly 
revealed that CX3CR1-expressing mac-
rophages exist as a layer of cells that forms a 
barrier, similar to a thin protective membrane, 
in the healthy joint (Fig. 1). This barrier forms 
as an outer layer of cells in the synovium, a 
region of the tissue that lines the joint. The 
barrier layer forms in a part of the synovium 
called called the lining layer, and it physically 
separates the synovial fluid (which bathes the 
joint) from the sublining layers of the syn-
ovium. The CX3CR1-expressing barrier-form-
ing macrophages are found adjacent to a layer 
of cells called fibroblasts in the lining layer. 
The authors carried out RNA sequencing, 
including single-cell sequencing, to profile the 
barrier macrophages. These cells express genes 
typically associated with barrier formation in 
a type of non-immune cell called an epithe-
lial cell. For example, the  macrophage profile 
included genes that encode proteins associ-
ated with the formation of a structure called 
a tight junction that connects epithelial cells 
by forming a ‘seal’ between adjacent epithelial 
cells. This is surprising, because macrophages 
are usually thought of as having a signalling 
or scavenging role, rather than having a struc-
tural, barrier-like function.
Using a mouse model of arthritis in which 
macrophages could be tracked by engineering 
them to be fluorescent, the authors observed 
that the barrier layer was highly dynamic. 
When arthritis was induced, the layer under-
went active remodelling that loosened the 
physical interactions between barrier mac-
rophages and lining-layer fibroblasts. Like 
other types of tissue-resident macrophage, the 
barrier macrophages can ingest and remove 
inflammatory immune cells called neutrophils 
that have accumulated and died in the synovial 
fluid during arthritis. 
When the authors induced arthritis in mice 
at the same time as they disrupted the barrier-
forming layer of macrophages through genetic 
or pharmacological manipulation, arthritis 
was exacerbated compared with animals in 
which the layer was intact. It would be inter-
esting to test whether transferring barrier 
macrophages directly into mouse joints could 
suppress arthritis. 
To explore the origin of the barrier-form-
ing, CX3CR1-expressing macrophages, the 
authors used intricate fate-mapping experi-
ments, which revealed that these cells are not 
derived from monocytes. They also found that 
monocytes did not give rise to the other type of 
macrophage that resides in the joint, termed an 
A R T H R I T I S [ O K ? ] 
An immune-cell 
barrier protects joints
Inflammation and the repair of damaged tissues are regulated by immune cells 
called macrophages. The finding that they form a layer that shields mouse joints 
from damage has implications for the treatment of arthritis. 
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Figure 1 | Barrier macrophages in the joint. Culemann et al.1 studied immune cells called macrophages 
in mouse and human joints. Joints are surrounded by a tissue called the synovium, which is formed from 
layers of cells called the lining and the sublining layers. The authors discovered that certain macrophages 
form a cell layer that protects joints from the inflammatory immune-cell attacks on bone and cartilage 
that are associated with arthritis. This barrier is formed in the lining layer, adjacent to a layer of cells 
called fibroblasts. The barrier-forming macrophages express proteins associated with a type of barrier-
forming cell called an epithelial cell, and these proteins form structures called tight junctions that ‘seal’ 
cells together. Barrier-forming macrophages arise from a type of macrophage called an interstitial 
macrophage, which resides in the sublining layer. By contrast, non-resident macrophages enter the joint 
from blood vessels. These cells, which can drive inflammation, arise from immune cells called monocytes. 
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interstitial synovial macrophage, which popu-
lates the sublining layer. The authors’ data are 
consistent with a model in which interstitial 
macrophages give rise to barrier macrophages. 
RNA-sequencing experiments revealed 
that interstitial macrophages can be divided 
into two groups. One group expressed the 
gene Retnla, whereas the other had a high 
level of expression of the genes that encode 
the proteins MHC class II and aquaporin. The 
macrophages that express MHC class II and 
aquaporin divide and differentiate either to 
form barrier macrophages or to form inter-
stitial macrophages that express Retnla.
To analyse the macrophage subsets that 
arise as arthritis develops, compared with 
those present in an uninflamed joint, the 
authors carried out further single-cell RNA 
sequencing. As expected from previous work7, 
monocyte-derived macrophages that produce 
pro-inflammatory molecules accumulated in 
the arthritic joint. They are recruited into the 
joint from the bloodstream by exiting blood 
vessels to enter the sublining layer. During 
the influx of these pro-inflammatory mac-
rophages, the barrier macrophages maintained 
their anti-inflammatory role, expressing the 
proteins needed for them to remove dead neu-
trophils from the joint. 
When the authors compared their single-
cell RNA data from mice with similar data 
sets8 available from an analysis of the joints 
of people with rheumatoid arthritis, the gene-
expression profiles of the macrophage subsets 
matched up across the two species. This sug-
gests that cells similar to the barrier and inter-
stitial macrophages in mice might also exist 
in humans, and thus possibly be relevant to 
human disease. 
The authors found that barrier macrophages 
were almost totally absent in synovial samples 
from people with active[OK for where ‘active’ 
should be placed?] rheumatoid arthritis, 
whereas they made up 10% of the macrophage 
population in samples from people who have 
osteoarthritis, a type of arthritis that is not 
associated with inflammation. It would be 
interesting to learn whether the population 
of barrier macrophages is restored in people 
whose rheumatoid arthritis is being success-
fully treated and in remission.
Culemann and colleagues’ work adds to 
studies3,4,9 showing that macrophages are 
exquisitely adapted to the functions they 
perform in the tissues in which they reside. 
Barrier macrophages join a growing list of 
types of macrophage that shield tissues from 
damage caused by infection, inflammation 
or cancer. Tissue-resident macrophages can 
prevent neutrophil-mediated inflammatory 
damage by physically shielding damaged tis-
sue from neutrophils10. Furthermore, in large 
body cavities, such as those surrounding the 
gut, heart and lungs, specialized macrophages 
have been described that are thought to repair 
mechanical damage3,9. These findings also 
complement the discovery of distinct subsets 
of fibroblasts, located in the sublining or lining 
regions of the joint, which, respectively, drive 
either inflammation or bone damage in arthri-
tis11. The challenge that lies ahead will be to 
develop ways of specifically targeting subsets 
of macrophages and fibroblasts with the ulti-
mate goal of developing new treatments for 
people with arthritis. ■
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